BRAIN Biotech AG Statistics
Total Valuation
FRA:BNN has a market cap or net worth of EUR 45.66 million. The enterprise value is 36.56 million.
Market Cap | 45.66M |
Enterprise Value | 36.56M |
Important Dates
The last earnings date was Wednesday, May 28, 2025.
Earnings Date | May 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 21.85M |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 8.90M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.85 |
PB Ratio | 6.35 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.68 |
EV / Sales | 0.68 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -5.48 |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.64.
Current Ratio | 1.85 |
Quick Ratio | 1.22 |
Debt / Equity | 0.64 |
Debt / EBITDA | n/a |
Debt / FCF | -0.69 |
Interest Coverage | -2.72 |
Financial Efficiency
Return on equity (ROE) is -102.10% and return on invested capital (ROIC) is -32.82%.
Return on Equity (ROE) | -102.10% |
Return on Assets (ROA) | -8.48% |
Return on Invested Capital (ROIC) | -32.82% |
Return on Capital Employed (ROCE) | -17.17% |
Revenue Per Employee | 180,804 |
Profits Per Employee | -46,142 |
Employee Count | 318 |
Asset Turnover | 0.70 |
Inventory Turnover | 2.55 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.91% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -24.91% |
50-Day Moving Average | 2.21 |
200-Day Moving Average | 2.59 |
Relative Strength Index (RSI) | 43.54 |
Average Volume (20 Days) | 4,775 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:BNN had revenue of EUR 53.52 million and -13.66 million in losses. Loss per share was -0.63.
Revenue | 53.52M |
Gross Profit | 29.12M |
Operating Income | -10.33M |
Pretax Income | -13.92M |
Net Income | -13.66M |
EBITDA | -6.94M |
EBIT | -10.33M |
Loss Per Share | -0.63 |
Balance Sheet
The company has 14.87 million in cash and 4.59 million in debt, giving a net cash position of 10.28 million.
Cash & Cash Equivalents | 14.87M |
Total Debt | 4.59M |
Net Cash | 10.28M |
Net Cash Per Share | n/a |
Equity (Book Value) | 7.19M |
Book Value Per Share | 0.28 |
Working Capital | 16.01M |
Cash Flow
In the last 12 months, operating cash flow was -5.35 million and capital expenditures -1.33 million, giving a free cash flow of -6.68 million.
Operating Cash Flow | -5.35M |
Capital Expenditures | -1.33M |
Free Cash Flow | -6.68M |
FCF Per Share | n/a |
Margins
Gross margin is 54.42%, with operating and profit margins of -19.31% and -25.52%.
Gross Margin | 54.42% |
Operating Margin | -19.31% |
Pretax Margin | -26.00% |
Profit Margin | -25.52% |
EBITDA Margin | -12.97% |
EBIT Margin | -19.31% |
FCF Margin | n/a |
Dividends & Yields
FRA:BNN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -29.91% |
FCF Yield | -14.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
FRA:BNN has an Altman Z-Score of -1.02. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.02 |
Piotroski F-Score | n/a |